ArticleCureus2026
Three Faces of Self-Destruction: A Case Series of Warm, Cold, and Mixed Autoimmune Hemolytic Anemia.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Autoimmune hemolytic anemia (AIHA) is an immune-mediated disorder in which red blood cells are destroyed by autoantibodies. It is classified as warm, cold, or mixed depending on the type of antibody involved. The clinical presentation can range from mild anemia to severe hemolysis, and it may occur as a primary condition or secondary to infections, autoimmune disorders, or hematological malignancies. Diagnosis relies on clinical findings combined with immunohematological tests, specifically the direct antiglobulin test (DAT). We describe the cases of three patients with different types of AIHA. The first patient was a 58-year-old woman who presented with severe anemia, low blood counts, and hepatosplenomegaly. Her blood tests revealed cold agglutinins and a positive DAT, and further evaluation identified B-cell acute lymphoblastic leukemia (B-ALL), confirming secondary cold AIHA. The second patient was a 55-year-old woman who presented with anemia, jaundice, and evidence of hemolysis, leading to a diagnosis of warm AIHA. The third patient was an 18-year-old woman who presented with severe anemia and splenomegaly. Her blood tests demonstrated both warm and cold antibody activity, and she was diagnosed with mixed AIHA. All three patients were treated with appropriate therapies and supportive care, resulting in clinical and hematological improvement. This case series illustrates the different ways AIHA can present and highlights the need for detailed immunohematological testing to identify the exact type, as well as the differences in treatment and management across AIHA subtypes. It also emphasizes the importance of searching for an underlying cause, as this guides treatment and improves outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.